IOBT

IO Biotech, Inc. IOBT

IOBT
IO Biotech, Inc. JSPR
Jasper Therapeutics, Inc. ADAP
Adaptimmune Therapeutics plc PSTV
Plus Therapeutics, Inc. EYEN
Eyenovia, Inc. FGEN
FibroGen, Inc. GBIO
Generation Bio Co. PDSB
PDS Biotechnology Corporation VRCA
Verrica Pharmaceuticals Inc. RVPH
Reviva Pharmaceuticals Holdings, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode IOBT JSPR ADAP PSTV EYEN FGEN GBIO PDSB VRCA RVPH
6M -25.15 % -33.67 % -23.29 % 1.24 % 596.26 % 59.08 % 93.37 % -6.05 % -14.41 % -11.09 %
YTD -28.04 % -87.67 % -70.47 % -42.37 % -22.40 % -16.55 % -39.55 % -43.52 % -41.68 % -68.64 %
1Y -44.02 % -85.70 % -78.86 % -52.45 % -83.07 % 17.57 % -72.72 % -69.18 % -72.85 % -48.75 %
3Y -73.87 % -66.23 % -84.13 % -91.45 % -96.36 % -97.38 % -87.27 % -76.05 % -86.01 % -82.92 %
5Y -95.74 % -97.38 % -97.08 % -98.31 % -97.52 % -99.04 % -97.42 % -58.77 % -95.28 % -94.11 %
10Y -95.74 % -97.35 % -97.47 % -100.00 % -99.06 % -97.98 % -97.28 % -99.78 % -97.66 % -93.51 %
From the beginning -95.74 % -97.35 % -98.85 % -100.00 % -99.06 % -97.99 % -97.28 % -99.56 % -97.66 % -93.51 %

Dividend